Medicine
Hazard ratio
Confidence interval
Crossover study
Placebo
Prostate cancer
Internal medicine
Metastatic Urothelial Carcinoma
Clinical endpoint
Proportional hazards model
Randomized controlled trial
Oncology
Urology
Cancer
Urothelial carcinoma
Bladder cancer
Pathology
Alternative medicine
